Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

ABSTRACT:

Background

Cystic fibrosis is an inherited condition causing disease most noticeably in the lungs, digestive tract and pancreas. People with cystic fibrosis often have malnutrition and growth delay. Adequate nutritional supplementation does not improve growth optimally and hence an anabolic agent, recombinant growth hormone, has been proposed as a potential intervention.

Objectives

To evaluate the effectiveness and safety of recombinant human growth hormone therapy in improving lung function, quality of life and clinical status of children and young adults with cystic fibrosis.

Search methods

We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register comprising references identified from comprehensive electronic database searches and handse

SUBMITTER: Thaker V 

PROVIDER: S-EPMC4465600 | biostudies-literature | 2013 Jun

REPOSITORIES: biostudies-literature